HIV-1 inhibitor-60
HIV-1 inhibitor-60 (compound 45) is an HIV inhibitor with the potential for the research of infection diseases[1].
Product Specifications
CAS Number
[1443461-21-9]
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hiv-1-inhibitor-60.html
Solubility
10 mM in DMSO
Smiles
CC(C)([C@](CC[C@@]([C@](CC[C@@]1([C@@H](O)CN(CC2=CC=CC(Cl)=C2)CCN(C)C)C3)4C)5C)6[H])[C@@H](OC(CC(C)(C(O)=O)C)=O)CC[C@]6(C)[C@@]5([H])CC[C@]4([H])C1=C(C(C)C)C3=O
Molecular Formula
C48H73ClN2O6
Molecular Weight
809.56
References & Citations
[1]Mark Andrew HATCHER, et al. Derivatives of botulin. Patent WO2013090664A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1188436-01 0.02 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acetate kinase (ackA)
Ask
View Details 
MBS1188436-02 0.02 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acetate kinase (ackA)
Ask
View Details 
MBS1188436-03 0.1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acetate kinase (ackA)
Ask
View Details MBS1188436-04 0.1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acetate kinase (ackA)
Ask
View Details MBS1188436-05 0.02 mg (Baculovirus)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acetate kinase (ackA)
Ask
View Details 
MBS1188436-06 0.02 mg (Mammalian-Cell)
Recombinant Yersinia pseudotuberculosis serotype O:3 Acetate kinase (ackA)
Ask
View Details